Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
News
Acceptance of telecare for MS varied with computer experience, disease duration
Publish date:
June 25, 2013
AT THE CMSC/ACTRIMS ANNUAL MEETING
nmiller@frontlinemedcom.com
On Twitter
@NaseemSMiller
Pages
« first
1
2
Recommended Reading
'Liberation therapy' may make MS worse
MDedge Internal Medicine
FDA approves Tecfidera for multiple sclerosis
MDedge Internal Medicine
All glucocorticoids linked to increased risk of VTE
MDedge Internal Medicine
Low weight may contribute to risk for natalizumab-induced PML
MDedge Internal Medicine
Reports indicate dalfampridine may worsen trigeminal neuralgia
MDedge Internal Medicine
Fingolimod slows MS brain atrophy within 6 months
MDedge Internal Medicine
Multiple sclerosis research in 2013: opportunities and challenges
MDedge Internal Medicine
In MS, 44% of excess mortality is potentially preventable
MDedge Internal Medicine
Case series finds rituximab beneficial in secondary-progressive MS
MDedge Internal Medicine
Peginterferon beta-1a shows promise in relapsing-remitting MS
MDedge Internal Medicine
Neurology
All Specialties
